Vimarsana
Biggest News Aggregation in the World

Page 2 - Late Breaking Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Late Breaking Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Late Breaking Science Today - Breaking & Trending Today

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science - Vimarsana News

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.

GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023 () - Vimarsana News

GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023 ()

GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023 () | aktiencheck.de

Börse Express - GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023 - Vimarsana News

Börse Express - GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023

^Allschwil, Switzerland - November 3, 2023

BÖRSE ONLINE – Seit 1987, Deutschlands erstes Börsenmagazin - Vimarsana News

BÖRSE ONLINE – Seit 1987, Deutschlands erstes Börsenmagazin

Seit 1987 hilft BÖRSE ONLINE Anlegern Woche für Woche bei ihren Investmententscheidungen.

Artivion Announces Presentation of Real World Data from Post Market Study of On-X Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin - Vimarsana News

Artivion Announces Presentation of Real World Data from Post Market Study of On-X Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

ATLANTA - Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced data from its On-X Aortic Heart Valve Low INR post-market study presented in a...